VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,435 | +483.6% | 673 | +500.9% | 0.00% | – |
| Q1 2023 | $760 | -81.3% | 112 | -79.6% | 0.00% | -100.0% |
| Q4 2022 | $4,065 | -32.2% | 550 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -60.0% | 646 | -52.6% | 0.00% | -50.0% |
| Q2 2022 | $15,000 | +87.5% | 1,364 | +101.5% | 0.00% | +100.0% |
| Q1 2022 | $8,000 | -20.0% | 677 | +4.8% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -9.1% | 646 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $11,000 | -21.4% | 646 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | +40.0% | 646 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $10,000 | +25.0% | 646 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +33.3% | 646 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | 0.0% | 646 | +17.5% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | 0.0% | 550 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |